|
Market Closed -
Other stock markets
|
After hours 19:48:41 | |||
| 48.28 USD | -3.44% |
|
44.06 | -8.73% |
| 07:33pm | European Equities Traded in the US as American Depositary Receipts Track Lower in Monday Trading | MT |
| 05:39pm | Eli Lilly May Raise Stake in Scribe Therapeutics to 10.9% Through IPO | MT |
| Market Cap | 92.83B 106B 85.66B 78.95B 149B 10,229B 152B 1,024B 403B 5,010B 399B 390B 17,246B | P/E 2026 * |
11.7x | P/E 2027 * | 10.7x |
|---|---|---|---|---|---|
| Enterprise Value | 102B 117B 94.54B 87.15B 164B 11,290B 168B 1,130B 444B 5,530B 440B 431B 19,036B | EV / Sales 2026 * |
2.18x | EV / Sales 2027 * | 1.97x |
| Free-Float |
89% | Yield 2026 * |
5.5% | Yield 2027 * | 5.83% |
Last Transcript: Sanofi
| 1 day | -8.73% | ||
| 1 week | +10.94% | ||
| Current month | +12.54% | ||
| 1 month | +14.42% | ||
| 3 months | +0.02% | ||
| 6 months | +3.37% | ||
| Current year | -0.77% |
| 1 week | 43 |  | 48.28 |
| 1 month | 40.8 | | 48.28 |
| Current year | 40.8 | | 49.57 |
| 1 year | 40.8 | | 52.65 |
| 3 years | 40.8 | | 60.08 |
| 5 years | 36.99 | | 60.08 |
| 10 years | 36.99 | | 60.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 01/05/2026 | |
| Director of Finance/CFO | 64 | 01/04/2024 | |
Houman Ashrafian
CTO | Chief Tech/Sci/R&D Officer | 51 | 11/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 30/04/2019 | |
Rachel Duan
BRD | Director/Board Member | 57 | 28/04/2020 |
Lise Kingo
BRD | Director/Board Member | 64 | 28/04/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.44% | +10.94% | - | - | 106B | |
| -1.25% | -0.85% | +53.74% | +152.63% | 1,051B | |
| -0.69% | -2.73% | +52.55% | +48.91% | 609B | |
| -0.18% | +2.61% | +37.66% | +78.96% | 450B | |
| -0.75% | +0.30% | +29.77% | +21.15% | 330B | |
| -1.52% | -1.19% | +34.46% | +35.35% | 284B | |
| -1.43% | -1.55% | +21.33% | +16.06% | 263B | |
| -0.58% | +1.11% | -20.18% | -40.59% | 223B | |
| -0.14% | +1.42% | +23.56% | +56.74% | 198B | |
| -0.38% | +1.83% | +23.58% | +67.39% | 167B | |
| Average | -1.56% | +0.54% | +28.50% | +48.51% | 397.23B | |
| Weighted average by Cap. | -1.08% | +0.02% | +37.69% | +72.84% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 46.94B 53.71B 43.31B 39.92B 75.25B 5,172B 76.92B 518B 204B 2,533B 202B 197B 8,720B | 50.02B 57.24B 46.16B 42.54B 80.19B 5,512B 81.97B 552B 217B 2,700B 215B 210B 9,293B |
| Net income | 8.33B 9.53B 7.68B 7.08B 13.35B 918B 13.64B 91.83B 36.12B 449B 35.78B 35B 1,547B | 9.22B 10.56B 8.51B 7.85B 14.79B 1,016B 15.12B 102B 40.02B 498B 39.64B 38.77B 1,714B |
| Net Debt | 9.63B 11.02B 8.89B 8.19B 15.44B 1,061B 15.78B 106B 41.78B 520B 41.39B 40.48B 1,789B | 5.52B 6.32B 5.09B 4.69B 8.85B 608B 9.04B 60.88B 23.94B 298B 23.72B 23.2B 1,025B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | $44.03 | -0.36% | 201,544 |
| 16/07/26 | $44.18 | +1.36% | 4,620 |
| 15/07/26 | $43.59 | +0.86% | 92,145 |
| 14/07/26 | $43.22 | -1.82% | 201 |
| 13/07/26 | $44.02 | +1.15% | 401 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SAN Stock
- 0A2V Stock
Select your edition
All financial news and data tailored to specific country editions
